Provention Bio, Inc. (NASDAQ:PRVB) Receives Average “Buy” Rating from AnalystsBy Publishing TeamJanuary 2, 2023 Shares of Provention Bio, Inc. (NASDAQ:PRVB – Get Rating) have received an average rating of “Buy” from the six rating…
